| |
| POWERPOINT DOWNLOADS |
 |
| This program has taken place. The following Powerpoint files from the presenters are available for download. |
|
|
|
|
|
|
|
|
|
|
| PRIOR SYMPOSIA |
|
| Although the following symposia have already taken place, you can download Powerpoint files used by the presenters and find additional information about many of these events. |
|
| • |
BACK TO CURRENT |
|
| • |
New York, NY |
| |
10/30/2007 |
|
| • |
Los Angeles, CA |
| |
10/24/2007 |
|
| • |
San Francisco, CA |
| |
09/26/2007 |
|
| • |
New York, NY |
| |
03/21/2007 |
|
| • |
Washington, DC |
| |
11/08/2006 |
|
| • |
Los Angeles, CA |
| |
10/25/2006 |
|
| • |
New York, NY |
| |
03/15/2006 |
|
| • |
Los Angeles, CA |
| |
10/26/2005 |
|
| • |
Rochester, NY |
| |
10/18/2005 |
|
| • |
Portland, ME |
| |
10/05/2005 |
|
| • |
MORE... |
|
| |
|
|
|
|
|
|
|
|
|
|
 |
Tuesday, October 30, 2007
CHALLENGES TO THE DIAGNOSIS AND EVALUATION, TREATMENT, AND MANAGEMENT OF CLUSTERED CARDIOMETABOLIC RISK FACTORS
• Attendance is FREE!
The program will be of interest to endocrinologists, diabetologists, cardiologists, and other health care professionals.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Challenges to the Diagnosis and Evaluation, Treatment, and Management of Clustered Cardiometabolic Risk Factors
New York Marriott East Side Hotel
525 Lexington Avenue
New York, NY 10017
|
 |
|
Program: 12:00 PM – 4:30 PM
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROGRAM |
|
| 12:00 PM |
Lunch and Registration
|
|
| 1:00 PM |
Welcome & Introduction
Wilson PW |
|
| 1:10 PM |
Hypertension and Obesity as Clustered Risk Factors: Considerations and Goals for Success in the Complex Patient
Black HR |
|
| 1:35 PM |
Questions and Answers
|
|
| 1:45 PM |
Metabolic Syndrome and Dyslipidemia: Effective Strategies for Lipid Management
Wilson PW |
|
| 2:10 PM |
Questions and Answers
|
|
| 2:20 PM |
Break
|
|
| 2:35 PM |
Managing Obesity and Diabetes as Major Modifiable Risk Factors for Coronary Heart Disease
Goldberg I |
|
| 3:00 PM |
Questions and Answers
|
|
| 3:10 PM |
Psychological Impact and Considerations for Treating the Obese Patient
Fabricatore AN |
|
| 3:35 PM |
Questions and Answers
|
|
| 3:45 PM |
An Interactive Panel Discussion: the Complex Patient-Case Examples
Wilson PW |
|
| 4:30 PM |
Adjournment |
|
|
|
|
|
CHAIR
Peter W. Wilson, MD, MPH
Professor of Medicine
Emory University School of Medicine
Atlanta, Georgia
ADDITIONAL SPEAKERS
Henry R. Black, MD
Clinical Professor of Internal Medicine
New York University School of Medicine
New York, New York
Anthony N. Fabricatore, PhD
Assistant Professor of Psychology
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
Ira Goldberg, MD
Professor of Medicine
Columbia University
New York, New York
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This program provides an opportunity to meet the experts and discuss evidence-based medicine as it relates to the clinical management of clustered cardiometabolic risk factors such as diabetes, hypertension, dyslipidemia, and obesity.
SYPOSIUM OBJECTIVES
Upon completion of this program, attendees should be able to:
• Discuss the effects of obesity on cardiovascular risk factors, diabetes, hypertension, and dyslipidemia and the necessity for early therapeutic intervention
• Identify sociocultural and psychological factors that may influence the development of obesity and the responses that may influence the treatment of obesity
• Discuss the current guidelines for optimal management of lipids and elevated blood pressure in the high risk patient
• Evaluate the role of combination therapy in the pharmacologic treatment of hypertension and lipid management
• Identify a combination of pharmacologic agents and lifestyle changes required to meet guideline targets for the patient with one or more of the metabolic syndrome cluster of risk factors: obesity, dyslipidemia, diabetes or glucose intolerance, and/or hypertension
ACCREDITATION STATEMENT
The American Society of Hypertension, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DESIGNATION STATEMENT
The American Society of Hypertension, Inc designates this educational activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Each physician should claim credit commensurate with the extent of their participation in the activity.
CME ACTIVITY
Sponsored by The American Society of Hypertension, Inc in cooperation with the Journal of the CardioMetabolic Syndrome. Funded by an unrestricted educational grant from Pfizer, Inc —its support is greatly appreciated.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
